Bill Sponsor
House Bill 3030
116th Congress(2019-2020)
Patient-Centered Outcomes Research Extension Act of 2019
Introduced
Introduced
Introduced in House on May 28, 2019
Overview
Text
Introduced
May 28, 2019
Latest Action
Jun 4, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3030
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Colorado
Democrat
Virginia
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Patient-Centered Outcomes Research Extension Act of 2019

This bill reauthorizes through FY2029 the Patient-Centered Outcomes Research Trust Fund, which supports research that evaluates and compares outcomes and the clinical effectiveness, risks, and benefits of two or more medical treatments, services, or other health practices.

Additionally, the bill extends specified fees on private health insurance plans, including self-insured plans, which support the trust.

Text (1)
Actions (4)
06/04/2019
Subcommittee Hearings Held.
05/29/2019
Referred to the Subcommittee on Health.
05/28/2019
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
05/28/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 6:17:29 AM